Shawn Hodges, PharmD

Shawn Hodges, PharmD, has a diverse work experience spanning multiple industries and roles. Shawn is currently serving as the Chief Executive Officer at Revelation Pharma Corporation since October 2022, and previously held the position of Chief Business Development Officer from December 2021 to October 2022 at the same company.

Prior to their current role, Hodges was the Owner of Innovation Compounding Pharmacy from May 2007 to October 2022. During their time there, they successfully managed the pharmacy as its owner.

Hodges also has experience in the pharmacy industry, having served as the Chairman of the Board at Alliance for Pharmacy Compounding (formerly IACP) from January 2021 to December 2021, and as the President from January 2020 to December 2020.

Before their roles in the compounding pharmacy industry, Hodges worked as a Regional Director at Hospice Pharmacia LLC from July 2003 to April 2007, overseeing operations in a specific region. Shawn also gained experience as a Pharmacist at Giant Foods from July 2002 to June 2003.

Hodges began their career as a Visiting Scientist at Eli Lilly and Company, where they completed a one-year fellowship from June 2001 to June 2002.

Overall, with their extensive experience in various leadership and pharmacist roles across different industries, Hodges brings a wealth of knowledge and expertise to their current leadership position at Revelation Pharma Corporation.

Shawn Hodges, PharmD, began their education at Texas Tech University in 1995, where they pursued a Doctor of Pharmacy (Pharm.D.) degree in the field of Pharmacy. Shawn completed this program in 1997. Later, from 1997 to 2001, they attended Texas Tech University Health Sciences Center, where they obtained a Doctor of Pharmacy (PharmD) degree, specializing in Pharmacy.